Clinical Trial Update: Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares continued immunosuppression versus stopping immunosuppression at six months in patients with late renal allograft failure t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Allograft Failure
• Renal Allograft Rejection

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Renal Failure , Chronic, Graft Failure | Phase 4 | Status: RECRUITING